Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Advanced Research Company Ltd (SPARC)

₹237.160.53%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Sun Pharma Advanced Research Company Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹234.42
    ₹239.49
  • 52 Week's Low

    52 Week's High

    ₹196.1
    ₹472.8
1 Month Return0 %
3 Month Return-39.18 %
1 Year Return+ 5.27 %
Previous Close₹235.90
Open₹236.80
Volume3.05L
Upper Circuit-
Lower Circuit-
Market Cap₹7,655.46Cr

Key Statistics

P/E Ratio-26.24
PEG Ratio4.07
Market Cap₹7,655.46 Cr
P/B Ratio11.36
EPS0

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Nippon India Nifty Smallcap 250 Index Fund Dir GrNippon India Nifty Smallcap 250 Index Fund Dir Gr0.14%
SBI Nifty Smallcap 250 Index Fund Direct GrowthSBI Nifty Smallcap 250 Index Fund Direct Growth0.14%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct GrowthMotilal Oswal Nifty Smallcap 250 Index Fund Direct Growth0.14%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct GrowthICICI Prudential Nifty Smallcap 250 Index Fund Direct Growth0.14%
HDFC Nifty Smallcap 250 Index Fund Direct GrowthHDFC Nifty Smallcap 250 Index Fund Direct Growth0.1%

Company Information

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Share Price: ₹237.16 per share as on 15 Jul, 2024 04:01 PM
Market Capitalisation: ₹7,655.46Cr as of today
Revenue: ₹16.56Cr as on March 2024 (Q1 24)
Net Profit: ₹-105.79Cr as on March 2024 (Q1 24)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd Stock Drops 42% - 13 Jul, 2024

    Sun Pharma Advanced Research Company Ltd stock has dropped by 42% in the last quarter, with revenue shrinking by 1.5% per year over the past five years. Despite this, the stock is up 9% each year during the same period and provided a TSR of 3.9% over the last twelve months.

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.24% to 0.25% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 30.21% to 30.28% in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 94.9% return, outperforming this stock by 89.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.9% return, outperforming this stock by 136.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 3.30% to 3.23% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SPARC stock has moved down by -39.2%

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹830.12Cr
↑196.39%
Total Liabilities
₹317.35Cr
↑27.53%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
-₹69.12Cr
↓66.81%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
3.23%
0.00
Mutual Funds
0.25%
0.00
Retail Investors
30.28%
0.00
Others
0.57%
0.00

Sun Pharma Advanced Research Company Ltd Valuation

Sun Pharma Advanced Research Company Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-50.79x)

January 5, 2024

Today (-26.24x)

July 12, 2024

Industry (59.98x)

July 12, 2024

Highest (0.00x)

December 29, 2023

LowHigh

Earnings and Dividends

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit fell -29.03% since last year same period to ₹-105.79Cr in the Q4 2023-2024. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -6.16% fall in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sun Pharma Advanced Research Company Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sun Pharma Advanced Research Company Ltd shares.

Sun Pharma Advanced Research Company Ltd (SPARC) share price today is ₹237.16

Sun Pharma Advanced Research Company Ltd is listed on NSE

Sun Pharma Advanced Research Company Ltd is listed on BSE

  • Today’s highest price of Sun Pharma Advanced Research Company Ltd is ₹239.49.
  • Today’s lowest price of Sun Pharma Advanced Research Company Ltd is ₹234.42.

PE Ratio of Sun Pharma Advanced Research Company Ltd is -26.24

PE ratio = Sun Pharma Advanced Research Company Ltd Market price per share / Sun Pharma Advanced Research Company Ltd Earnings per share

Today’s traded volume of Sun Pharma Advanced Research Company Ltd(SPARC) is 3.05L.

Today’s market capitalisation of Sun Pharma Advanced Research Company Ltd(SPARC) is ₹7655.46Cr.

Sun Pharma Advanced Research Company Ltd(SPARCPrice
52 Week High
₹472.8
52 Week Low
₹196.1

Sun Pharma Advanced Research Company Ltd(SPARC) share price is ₹237.16. It is down -49.84% from its 52 Week High price of ₹472.8

Sun Pharma Advanced Research Company Ltd(SPARC) share price is ₹237.16. It is up 20.94% from its 52 Week Low price of ₹196.1

Sun Pharma Advanced Research Company Ltd(SPARCReturns
1 Day Returns
1.26%
1 Month Returns
0%
3 Month Returns
-39.18%
1 Year Returns
5.27%